PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “AFRICA, NORTHERN”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 145 records · Page 8Linked to original sources
PubMed2001

Prevalence and patterns of child sexual abuse and victim-perpetrator relationship among secondary school students in the northern province (South Africa).

An investigation into the prevalence and characteristics of child sexual abuse in the Northern Province (South Africa) was conducted. A total of 414 secondary school students in standard 9 and 10 in three representative secondary schools completed a retrospective self-rating questionnaire in a classroom setting. The questionnaire asked about childhood sexual abuse and the victim-perpetrator relationship. Results shows an overall (N = 414) child sexual abuse prevalence rate of 54.2%, 60% for males (N = 193), 53.2% for females (N = 216). Among them, 86.7% were kissed sexually, 60.9% were touched sexually, 28.9% were victims of oral/anal/vaginal intercourse. "Friend" was the highest indicated perpetrator in all patterns of sexual abuse. Many victims (86.7%) perceived themselves as not sexually abused as a child, and many (50.2%) rated their childhood as "very happy." A call is made for more research, publicity, and campaigns in the area of child sexual abuse in the Province.

Adolescent↗
PubMed1976

[World trends in infant mortality since 1950].

Despite the considerable progress made in recent decades, and perhaps even partly because of the very uneven distribution of this progress, infant mortality is still very high in some regions, whereas in other regions it is tending, if not disappear completely, at least to become numerically negligible even though remaining a matter of social concern. Whereas in tropical Africa almost one child in five dies before its first birthday, in Japan or Scandinavia it is one child in a hundred. Infant mortality rate varies between these two extremes, but there is a substantial gulf between the "most developed" regions which are all below 30% and the "least developed" regions which fall into three categories: 65-100% (Latin America, Eastern Asia except Japan), around 140% (Northern Africa, South Asia, Melanesia), and about 200% (topical Africa). These inequalities between countries overlap with inequalities between social groupings by urbanization, social/occupational level, education and income, are all variables that are correlated with infant mortality to a greater or lesser degree. The pace of the progress achieved since 1950 seems to be independent of the starting level. Contrary to the development of mortality at other ages, it is not in the countries with high mortality that infant mortality has decreased most. The pace of reduction divides the most developed regions into three distinct groups: very rapid reduction (Japan), rapid reduction (Scandinavia, Western Europe, Southern Europe and Eastern Europe), and slower reduction (British Isles, Northern America and Australia/New Zealand). Thus Japan rapidly caught up with Western Europe and the English-speaking countries and has now reached the same level as Scandinavia. On the other hand, the English-speaking countries have fallen behind the Scandinavian countries and are now at par with Western Europe. The reduction of infant mortality mainly concerned deaths of children over one month of age or even over one week of age and otherwise is due to reduction of infectious diseases. Consequently, in the most developed regions mortality is highly concentrated in the first week of life and is mainly attributable to the "causes of perinatal mortality" and the "congenital" anomalies". In the least developed regions, on the other hand, the infectious or parasitic diseases are still of decisive importance and the risk of death remains very high throughout the first year of life and even beyond. The risk may be even higher during the second year, when weaning takes place abruptly and results in serious difficulties in feeding.

Age Factors↗
PubMed2005

New evidence on deinonychosaurian dinosaurs from the Late Cretaceous of Patagonia.

Most of what is known about the evolution of deinonychosaurs (that is, the group of theropods most closely related to birds) is based on discoveries from North America and Asia. Except for Unenlagia comahuensis and some fragmentary remains from northern Africa, no other evidence was available on deinonychosaurian diversity in Gondwana. Here we report a new, Late Cretaceous member of the clade, Neuquenraptor argentinus gen. et sp. nov., representing uncontroversial evidence of a deinonychosaurian theropod in the Southern Hemisphere. The new discovery demonstrates that Cretaceous theropod faunas from the southern continents shared greater similarity with those of the northern landmasses than previously thought. Available evidence suggests that deinonychosaurians were probably distributed worldwide at least by the beginning of the Cretaceous period. The phylogenetic position of the new deinonychosaur, as well as other Patagonian coelurosaurian theropods, is compatible with a vicariance model of diversification for some groups of Gondwanan and Laurasian dinosaurs.

Argentina↗
PubMed1997

Typing of urinary JC virus DNA offers a novel means of tracing human migrations.

Although polyomavirus JC (JCV) is the proven pathogen of progressive multifocal leukoencephalopathy, the fatal demyelinating disease, this virus is ubiquitous as a usually harmless symbiote among human beings. JCV propagates in the adult kidney and excretes its progeny in urine, from which JCV DNA can readily be recovered. The main mode of transmission of JCV is from parents to children through long cohabitation. In this study, we collected a substantial number of urine samples from native inhabitants of 34 countries in Europe, Africa, and Asia. A 610-bp segment of JCV DNA was amplified from each urine sample, and its DNA sequence was determined. A worldwide phylogenetic tree subsequently constructed revealed the presence of nine subtypes including minor ones. Five subtypes (EU, Af2, B1, SC, and CY) occupied rather large territories that overlapped with each other at their boundaries. The entire Europe, northern Africa, and western Asia were the domain of EU, whereas the domain of Af2 included nearly all of Africa and southwestern Asia all the way to the northeastern edge of India. Partially overlapping domains in Asia were occupied by subtypes B1, SC, and CY. Of particular interest was the recovery of JCV subtypes in a pocket or pockets that were separated by great geographic distances from the main domains of those subtypes. Certain of these pockets can readily be explained by recent migrations of human populations carrying these subtypes. Overall, it appears that JCV genotyping promises to reveal previously unknown human migration routes: ancient as well as recent.

Adult↗
PubMed2001

[Occurrence of foot and mouth disease--a historical survey].

FMD--the most economically significant animal disease in the world during the last two centuries--has caused the last great panzootic from 1965 to 1967 in Europe. Since then it has become possible to eradicate centres of the epidemic still being present on the continent, mainly by means of the annual mass vaccination of cattle combined with rigid antiepizootic measures which include culling of infected animals. During the years after however there has been sporadic outbreaks again and again. They were mainly caused by virus that escaped from FMD laboratories and by the application of vaccines with residual infectiousity but also to an increasing extent they resulted from virus brought in from endemic regions of the world. The now as before high incidence of FMD in Asia and in wide parts of Africa and South America--after all 71 countries in these regions have been affected by outbreaks of FMD, the classic carrier disease, from 1998 to 2000--resulted in the spread of virus over far distances due to the globalization of world trade and the increasing traveling favoured by modern traffic facilities. Since 1980 in Europe particularly virus strains from the Middle East but also from other parts of Northern Africa and Asia have dominated the epidemiological situation such as the current epizootic in the United Kingdom and the outbreaks resulting from in three other member states of the European Union. In accordance with the EU guidelines the control of occurring outbreaks is exclusively carried out by stamping out. The limits of this procedure have become clearly obvious during the current epizootic in Britain. The use of emergency vaccination in the Netherlands shows a practicable alternative to the excessive mass culling of both infected animals and those being suspected of. The plurality and variability of the causative agent require a permanent observation of the epidemiological situation and of the virus strains involved in order to prevent the disease and to ensure the diagnosis and the topicality of the vaccines being available in the vaccine banks. Long-term success in the global combat against FMD can only be achieved on the basis of close international co-operation intended to restrain the disease significantly in the still endemically infected regions.

Animals↗
PubMed1999

Progress towards the eradication of poliomyelitis globally and in Africa, January 2000.

Led by an international partnership including Rotary International, the WHO, UNICEF and the Centers for Disease Control and Prevention in the USA, the global initiative to eradicate poliomyelitis has made remarkable progress since its beginning in 1988. The number of polio cases has decreased from an estimated 350,000 cases in 1988 to just over 5,000 reported cases in 1999. Following successful eradication from the WHO Region of the America's, certified as polio-free in 1994, wild poliovirus was last reported from the Western Pacific Region (including China) in 1997, and from the European Region (including all countries of the former Soviet Union) in November 1998. Large parts of Southern and Northern Africa and the Middle East are also polio-free. This success is related to the implementation of annual nationwide supplemental oral poliovaccine (OPV) campaigns in all recently or currently polio-endemic countries, targeting all children under 5 years with two doses of OPV. Progress of the initiative is monitored by special surveillance systems for all cases of acute flaccid paralysis (AFP) in children under 15 years, including virological testing to rule out wild poliovirus infection. The initiative currently focuses on a limited number of remaining endemic countries in South Asia and Africa, including India, Pakistan, Bangladesh, and Nigeria. The initiative is also beginning to be successful in several countries affected by conflict situations, such as Afghanistan, Sudan (South), Somalia, Democratic Republic of the Congo and Angola.

Acute Disease↗
PubMed1989

Epidemiological study of neuro-cysticercosis in northern Togo (West Africa).

In april 1987, an epidemiologic study in Northern Togo was carried out in order to evaluate the prevalence of cysticercosis and epilepsy. The survey also aimed to investigate possible connections between these two illnesses. The study encompassed 5264 subjects over 15 years old, selected using random sampling techniques; 125 cases of cysticercosis were diagnosed (2.4% of sample population); 12 by anatomo-pathological examination of cysts 18 (14.4%) based on skull and muscle x-ray calcifications and 104 patients were identified using ELISA tests on 1527 serum samples (optical density greater than or equal to 0.4). Among 88 epileptic patients (prevalence = 16.7 per thousand), 27 also suffered from cysticercosis (38.7% of all epileptic patients, 21.6% of cysticercosis patients and 0.51% of the total population).

Adolescent↗
PubMed2000

Mitochondrial sequence analysis of Salamandra taxa suggests old splits of major lineages and postglacial recolonizations of central Europe from distinct source populations of Salamandra salamandra.

Representatives of the genus Salamandra occur in Europe, Northern Africa and the Near East. Many local variants are known but species and subspecies status of these is still a matter of dispute. We have analysed samples from locations covering the whole expansion range of Salamandra by sequence analysis of mitochondrial D-loop regions. In addition, we have calibrated the rate of divergence of the D-loop on the basis of geologically dated splits of the closely related genus Euproctus. Phylogenetic analysis of the sequences suggests that six major monophyletic groups exist (S. salamandra, S. algira, S. infraimmaculata, S. corsica, S. atra and S. lanzai) which have split between 5 and 13 million years ago (Ma). We find that each of the Salamandra species occupies a distinct geographical area, with the exception of S. salamandra. This species occurs all over Europe from Spain to Greece, suggesting that it was the only species that has recolonized Central Europe after the last glaciation. The occurrence of specific east and west European haplotypes, as well as allozyme alleles in the S. salamandra populations suggests that this recolonization has started from at least two source populations, possibly originating in the Iberian peninsula and the Balkans. Two subpopulations of S. salamandra were found that are genetically very distinct from the other populations. One lives in northern Spain (S. s. bernardezi) and one in southern Italy (S. s. gigliolii). Surprisingly, the mitochondrial lineages of these subpopulations group closer together than the remainder S. salamandra lineages. We suggest that these populations are remnants of a large homogeneous population that had colonized Central Europe in a previous interglacial period, approximately 500 000 years ago. Animals from these populations were apparently not successful in later recolonizations. Still, they have maintained their separate genetic identity in their areas, although they are not separated by geographical barriers from very closely related neighbouring populations.

Animals↗
PubMed1998

The viral origin of cervical cancer in Rabat, Morocco.

In Northern Africa, cervical cancer is the second most common cancer among women. The diagnosis is usually made in advanced stages, and mortality is high, yet few studies have investigated the role of human papillomavirus (HPV) and other risk factors in the etiology of cervical cancer. A hospital-based case-control study was completed at the Institut National d'Oncologie (INO) in Rabat, Morocco. The study included 214 cases of invasive cervical cancer and 203 controls. A structured questionnaire was used to investigate known and suspected risk factors for cervical cancer. A GP 5+/6+ polymerase chain reaction system was used to detect the presence of HPV DNA and HPV type distribution. Probes for 30 HPV types were used in one research laboratory. HPV DNA was the central risk factor and accounted for the large majority of the cases. The adjusted odds ratio (ORa) for any HPV was 61.6 (95% CI, 29.2-130) and the corresponding HPV attributable fraction (AF) was 92%. Among cases of cervical cancer, HPV 16 was the most common type (67.7%) followed by HPV 18. The HPV type-specific prevalence was similar for squamous cell carcinomas and adenocarcinomas. In multivariate adjusted or HPV-stratified analyses, in addition to the strong effect of HPV, other risk factors identified were sexual intercourse with multiple partners before the age of 20 and low socio-economic status. Use of oral contraceptives for 5 or more years and high parity were also found to be related to cervical cancer. Screening was rare in this population but offered substantial protection against cervical cancer. In Morocco, cervical cancer is a late sequel of a viral infection with certain HPV types. Developing screening programs for preneoplastic cervical lesions is a public health priority. When available, HPV vaccination would offer a relevant alternative for preventing cervical cancer.

Adenocarcinoma↗
PubMedDate not supplied

Genetic position of Valencia (Spain) in the Mediterranean basin according to Alu insertions.

In this work, eight human-specific Alu insertion polymorphisms (ACE, TPA25, PV92, APO, FXIIIB, D1, A25, and B65) were typed in 106 unrelated healthy individuals born in the province of Valencia (Spain), with the aim of analyzing the genetic relationships between this region of the Iberian Peninsula and other Mediterranean populations. To that end, Alu data on Eastern European, Western European, and North African populations were compiled from previous studies. The genetic information was stressed by means of genetic distances (R matrix method), nonmetric multidimensional scaling (MDS) and analyses of molecular variance (AMOVA). In Valencia, the most common Alu insertion was APO (0.940), and the least frequent was A25 (0.104). The average gene diversity (GD) computed for the sample examined was comparatively high (0.382). The insertion frequencies estimated for the eight Alu markers were very similar to the mean frequencies calculated for the whole set of populations included in the study, suggesting the hybrid nature of the Valencia's gene pool. MDS and AMOVA results generated from Alu data reveal that the Mediterranean has acted as a strong genetic boundary between the north (Europe) and the south (Northern Africa), resulting in significant gene diversity between the populations of the two regions. Restricted exclusively to the European scope, we suggest the possibility that the Mediterranean could have also acted as a migratory passageway, propitiating the dissemination of cultures and genes between the east and west of Europe and giving rise to some homogenization of gene frequencies among coastal dwelling populations.

Alu Elements↗
PubMed2004

Against which human papillomavirus types shall we vaccinate and screen? The international perspective.

At least 15 types of HPV have been associated with cervical cancer, but current HPV vaccines confer only type-specific immunity. To determine geographic variations in the HPV type distribution in cervical cancer, we carried out a pooled analysis of data from an international survey of HPV types in cervical cancer and from a multicenter case-control study, both co-coordinated by the IARC. Study cases were 3,607 women with incident, histologically confirmed cervical cancer recruited in 25 countries. HPV DNA detection and typing in cervical cells or biopsies were centrally done using PCR assays. Estimates of the potential number of cases prevented by HPV type-specific vaccines and changes in the validity of different HPV screening cocktails were calculated. HPV DNA was detected in 96% of specimens, and 30 different types were detected. The 15 most common types were, in descending order of frequency, 16, 18, 45, 31, 33, 52, 58, 35, 59, 56, 39, 51, 73, 68 and 66. Higher than average proportions of type 16 were found in northern Africa, of type 18 in south Asia, of type 45 in sub-Saharan Africa and of type 31 in Central/South America. A vaccine including types 16 and 18 could potentially prevent 71% of cervical cancers worldwide, but its impact with regard to the percentage of cases potentially prevented would be higher in Asia and Europe/North America. In contrast, a vaccine containing the 7 most common HPV types would prevent about 87% of cervical cancers worldwide, with little regional variation. The impact of modifying the number of types in the screening cocktail tests would be small and probably irrelevant for screening programs.

Africa↗
PubMed2006

High frequency of latent membrane protein-1 30-bp deletion variant with specific single mutations in Epstein-Barr virus-associated nasopharyngeal carcinoma in Moroccan patients.

Latent membrane protein 1 (LMP-1) is an Epstein-Barr virus-encoded oncoprotein expressed in approximately 50-70% of nasopharyngeal carcinoma (NPC). Previous studies have shown that NPC-derived LMP-1 variants carrying 30 bp deletion and specific mutations in the 3'C-terminal region confer high oncogenic potential and a weak immunogenicity. Although numerous polymorphism studies of LMP-1 have been carried out so far in the Asian population with NPC, very little is known in this regard on NPC patients from Northern Africa where there is a significantly high occurrence of this tumor. In our study, we examined the frequency of different LMP-1 sequence variants derived from Moroccan NPC patients. As compared to healthy donors, NPC patients showed a high prevalence of the 30bp deletion variant of LMP-1 (i.e. 84% vs. 36%; p<0.0005). Moreover, the del-LMP-1 variant derived from NPC tumors shared identical amino acid substitutions at positions 322, 334, 338, 352 and 366 with the Mediterranean (Med) variant, whereas those derived from peripheral blood mononuclear cells (PBMC) had similar mutation pattern as China1 variant. Additional mutations within the 342-352 regions (identified in LMP-1 variants without deletion derived from NPC tumors) were not found in healthy donors' PBMC. Our results support the assumption that the distribution of LMP-1 variants in NPC tumors co-segregate with geographic regions. Indeed, Med variant is found more frequently in tumors from NPC Moroccan patients, whereas China1 variant is more prevalent in tumors from NPC patients in endemic regions for NPC.

Base Sequence↗
PubMed2007

Cancer incidence in eastern Libya: the first report from the Benghazi Cancer Registry, 2003.

Cancer registration in Northern Africa is still limited and, until now, there have been no population-based data available for Libya. In this paper, we present the first data collected and analyzed by the Benghazi Cancer Registry. Registration was carried out by active data collection; the registry staff routinely visited all hospitals and pathological laboratories in eastern Libya (1.6 million inhabitants) and collected information from all death registration offices. A huge archive of prevalent cases was established before the 2003 data were collected. A total of 997 cases of primary cancers were registered among residents in 2003. The world age-standardized incidence rate for all sites combined (except nonmelanoma skin) was 118 per 100,000 for men and 95 per 100,000 for women. The most frequently diagnosed malignancies in males were lung cancer (19%) and colorectal cancer (10%), followed by cancers of the head and neck (9%) and bladder (9%). Among females, they were breast cancer (26%), cancer of the colon and rectum (9%), uterus (7%) and non-Hodgkin lymphoma (5%). Our study provides data on cancer incidence in eastern Libya, and confirms that cancer incidence is much lower than in western countries. Moreover, observed patterns indicate that the incidence of many cancers, including those of the lung, breast, colon, rectum and bladder is quite different from previous estimates based on the data available from the neighboring countries.

Adolescent↗
PubMed2005

The critical impact of Frantz Fanon and Henri Collomb: race, gender, and personality testing of North and West Africans.

In 2001, the U.S. Surgeon General declared publicly that culture counts in mental health care. This welcome recognition of the role of culture in mental health appears somewhat belated. In 1956, Frantz Fanon and Henri Collomb both presented culturally sensitive studies of the Thematic Apperception Test at the major French-language mental health conference. The contrast between these two studies and between the careers of Fanon and Collomb reveals some of the difficulties in creating cultural and gender sensitivity in psychiatry or psychology.

Africa, Northern↗